跳至主要内容
临床试验/NCT07082426
NCT07082426进行中(未招募)不适用

EASE Study: Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human Study

Abbott Medical Devices3 个研究点 分布在 2 个国家目标入组 8 人开始时间: 2024年11月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
8
试验地点
3
主要终点
Technical Success

研究概览

简要总结

Early System Experience with the Abbott Balloon-expandable TAVI System

详细描述

The Early System Experience with the Abbott's balloon-expandable TAVI System first-in-human study ('EASE study') will evaluate preliminary clinical evidence on the safety and feasibility of the Abbott's balloon-expandable TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Increased surgical risk
  • •Appropriate anatomy
  • •At least 18 years of age
  • •Willing to return for follow-up assessments

排除标准

  • •Pregnant or nursing subjects
  • •Anatomic or comorbid conditions
  • •Evidence of acute myocardial infarction
  • •Inoperable/ineligible for surgery
  • •Renal disease requiring chronic dialysis

研究组 & 干预措施

Balloon expandable TAVI

Experimental

干预措施: Balloon expandable TAVI (Device)

结局指标

主要结局

Technical Success

时间窗: Post procedure

Successful access, delivery of the Abbott BE TAVI valve, and retrieval of the delivery system.

Device success

时间窗: 30 days

Intended performance of the valve

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验